acetylleucyl-leucyl-norleucinal has been researched along with n-benzyloxycarbonyl-leucyl-leucyl-phenylalaninal in 1 studies
Studies (acetylleucyl-leucyl-norleucinal) | Trials (acetylleucyl-leucyl-norleucinal) | Recent Studies (post-2010) (acetylleucyl-leucyl-norleucinal) | Studies (n-benzyloxycarbonyl-leucyl-leucyl-phenylalaninal) | Trials (n-benzyloxycarbonyl-leucyl-leucyl-phenylalaninal) | Recent Studies (post-2010) (n-benzyloxycarbonyl-leucyl-leucyl-phenylalaninal) |
---|---|---|---|---|---|
321 | 0 | 53 | 8 | 0 | 1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cresswell, P; Hughes, EA; Ortmann, B; Surman, M | 1 |
1 other study(ies) available for acetylleucyl-leucyl-norleucinal and n-benzyloxycarbonyl-leucyl-leucyl-phenylalaninal
Article | Year |
---|---|
The protease inhibitor, N-acetyl-L-leucyl-L-leucyl-leucyl-L-norleucinal, decreases the pool of major histocompatibility complex class I-binding peptides and inhibits peptide trimming in the endoplasmic reticulum.
Topics: Amino Acid Sequence; Biological Transport; Carrier Proteins; Cell Compartmentation; Cysteine Proteinase Inhibitors; Cytosol; Endoplasmic Reticulum; Histocompatibility Antigens Class I; Leupeptins; Molecular Sequence Data; Oligopeptides; Peptides; Protein Binding | 1996 |